TipRanks
Advertisement
Advertisement

DE:08D Stock Latest News

Mirum Pharmaceuticals price target raised to $130 from $123 at Baird
The FlyMirum Pharmaceuticals price target raised to $130 from $123 at Baird
2d ago
MIRM
Mirum Pharmaceuticals price target raised to $160 from $145 at Citi
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $160 from $145 at Citi
2d ago
MIRM
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
PremiumRatings
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
2d ago
MIRM
Vir Biotechnology in favorable position following Mirum data, says Needham
PremiumThe Fly
Vir Biotechnology in favorable position following Mirum data, says Needham
3d ago
VIR
MIRM
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
PremiumRatings
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
3d ago
MIRM
Mirum Pharmaceuticals price target raised to $195 from $140 at H.C. Wainwright
PremiumThe FlyMirum Pharmaceuticals price target raised to $195 from $140 at H.C. Wainwright
3d ago
MIRM
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
Premium
Company Announcements
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
3d ago
8K
MIRM
Mirum Pharmaceuticals says primary endpoint met in Phase 3 AZURE-1 study
Premium
The Fly
Mirum Pharmaceuticals says primary endpoint met in Phase 3 AZURE-1 study
3d ago
MIRM
Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz
PremiumThe Fly
Mirum Pharmaceuticals, Incyte announce FDA approval of Atebrioz
6d ago
INCY
MIRM
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
PremiumCompany Announcements
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
23d ago
8K
MIRM
Mirum Pharmaceuticals appoints Myers as Chief Medical Officer
PremiumThe Fly
Mirum Pharmaceuticals appoints Myers as Chief Medical Officer
23d ago
MIRM
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
PremiumCompany Announcements
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
1M ago
MIRM
Mirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
PremiumRatingsMirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
1M ago
MIRM
Mirum sinks after FDA recommends conducing Phase 3 study
Premium
The Fly
Mirum sinks after FDA recommends conducing Phase 3 study
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $140 from $145 at TD Cowen
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $140 from $145 at TD Cowen
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $137 from $150 at Morgan Stanley
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $137 from $150 at Morgan Stanley
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $135 from $148 at RBC Capital
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $135 from $148 at RBC Capital
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $140 from $185 at H.C. Wainwright
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $140 from $185 at H.C. Wainwright
2M ago
MIRM
Mirum Pharmaceuticals price target lowered to $137 from $146 at Citizens
PremiumThe FlyMirum Pharmaceuticals price target lowered to $137 from $146 at Citizens
2M ago
MIRM
Mirum Pharmaceuticals reports Q2 EPS ($1.06), consensus (75c)
Premium
The Fly
Mirum Pharmaceuticals reports Q2 EPS ($1.06), consensus (75c)
2M ago
MIRM
Mirum treatment of primary sclerosing cholangitis granted FDA orphan status
Premium
The Fly
Mirum treatment of primary sclerosing cholangitis granted FDA orphan status
2M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >